by Plus Therapeutics | May 6, 2024 | GBM
➡️ GLIOBLASTOMA PATIENT WEBINAR ⬅️ Join us as the @MusellaFoundation hosts Dr. Andrew Brenner and Dr. Marc Hedrick in a discussion about the ReSPECT-GBM Phase 2 Clinical Trial for Recurrent Glioblastoma. The webinar will take place May 20 2pm EST with a recording to...
by Plus Therapeutics | May 3, 2024 | Uncategorized
Reminder to come stop by the Plus Therapeutics booth #1057 at the American Association of Neurological Surgeons (AANS) annual conference this weekend in Chicago! Our team will be in the exhibit hall during the entire conference, so come say hello 👋 #AANS2024...
by Plus Therapeutics | May 2, 2024 | LM
❗NEW CLINICAL TRIAL INVESTIGATION SITE❗ We are pleased to announce the addition of North Shore University Hospital in New York to our ReSPECT-LM Clinical Trial with Principal Investigator Michael Schulder, M.D.. This site is NOW ENROLLING patients. Michael Schulder,...
by Plus Therapeutics | May 1, 2024 | Uncategorized
Brain tumor research is at the heart of what we do. Our team focuses every day on how to fight for a cure, and we are passionate about the Brain Cancer community. 🧠🎗️ We have some great education events and news this month that we look forward to sharing with you all,...
by Plus Therapeutics | Apr 29, 2024 | PBC
Following our EXCITING NEWS about our $3 Million award recommendation from the United States Department of Defense, we wanted to reshare our cancer guides for Pediatric High-Grade Glioma (https://www.respect-trials.com/patient-guide-hgg/) and Ependymoma...
Recent Comments